Suppr超能文献

荨麻疹和血管性水肿的最新进展

Update on Urticaria and Angioedema.

作者信息

Szymanski Kate, Schaefer Paul

机构信息

Department of Family Medicine, College of Medicine and Life Sciences at the University of Toledo Medical Center, 3333 Glendale Avenue, Toledo, OH 43614-2598, USA.

Department of Family Medicine, College of Medicine and Life Sciences at the University of Toledo Medical Center, 3333 Glendale Avenue, Toledo, OH 43614-2598, USA.

出版信息

Med Clin North Am. 2024 Jul;108(4):687-702. doi: 10.1016/j.mcna.2023.08.004.

Abstract

Urticaria and angioedema are caused by immunoglobulin E- and non-immunoglobulin E-mediated release of histamine and other inflammatory mediators from mast cells and basophils. Diagnosis is made clinically, and anaphylaxis must be ruled out if urticaria or angioedema is present. A limited nonspecific laboratory workup should be considered unless elements of the history or physical examination suggest specific underlying conditions. The mainstay of treatment is avoidance of triggers when and if triggers are identified. The first-line pharmacotherapy is second-generation H1 antihistamines, which can be titrated to greater than standard doses.

摘要

荨麻疹和血管性水肿是由免疫球蛋白E介导和非免疫球蛋白E介导的组胺及其他炎症介质从肥大细胞和嗜碱性粒细胞释放所引起的。诊断依靠临床判断,若出现荨麻疹或血管性水肿,必须排除过敏反应。除非病史或体格检查的某些因素提示有特定的潜在疾病,否则应考虑进行有限的非特异性实验室检查。治疗的主要方法是在确定触发因素时避免接触这些因素。一线药物治疗是使用第二代H1抗组胺药,可将剂量滴定至高于标准剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验